Early research (Phase 1)Study completedNCT00516373
What this trial is testing
Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)
Who this might be right for
Ovarian NeoplasmsBRCA1 ProteinBRCA2 Protein
AstraZeneca 98